ClinicalTrials.Veeva

Find clinical trials for Colon Cancer in Roma, Lazio

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Colorectal Cancer
Colonic Cancer
Cancer
Neoplasm Metastasis
Adenocarcinoma
Lung Cancer
Pancreatic Cancer

Colon Cancer trials near Roma, Lazio, ITA:

Exploiting Circulating Tumour DNA to Intensify the Postoperative Treatment Resected Colon Cancer Patients (ERASE-CRC)

cohort of HER2+ RAS wild-type colon cancer patients will be assessed for ct-DNA clearance after a tailored treatment with Trastuzu...

Enrolling
RAS Wild-type Colon Cancer
Stage II Colon Cancer
Drug: 5-Fluorouracil continuous infusion FOLFOXIRI schedule
Drug: L-Leucovorin

Phase 2

Gruppo Oncologico del Nord-Ovest

Roma, Italy and 27 other locations

(SOC) in participants with untreated T4N0 or Stage III (resectable), defective mismatch repair/ microsatellite instability high (dMMR/MSI-H) colon...

Enrolling
Colonic Neoplasms
Neoplasms, Colon
Drug: FOLFOX
Biological: Dostarlimab

Phase 3

GlaxoSmithKline (GSK)
GlaxoSmithKline (GSK)

Roma, Lazio, Italy and 212 other locations

Study 849-010 is an open-label, randomized Phase 3 clinical trial comparing the efficacy of MRTX849 administered in combination with cetuximab versus...

Active, not recruiting
Metastatic Colorectal Cancer
Advanced Colorectal Cancer
Drug: MRTX849
Drug: mFOLFOX6 Regimen

Phase 3

Mirati Therapeutics
Mirati Therapeutics

Roma, Italy and 308 other locations

The main purpose of this study is to demonstrate the superiority of S 95005 in combination with bevacizumab over capecitabine in combination with bev...

Active, not recruiting
Metastatic Colorectal Cancer
Biological: Bevacizumab experimental
Drug: Trifluridine/tipiracil hydrochloride (S95005)

Phase 3

Servier
Servier

Roma, Italy and 189 other locations

Phase 1 dose escalation will determine the first cycle dose-limiting toxicities (DLTs), the maximum tolerated dose (MTD), the biologically effective...

Enrolling
Locally Advanced Solid Tumors
Metastatic Solid Tumors
Drug: Oral repotrectinib (TPX-0005)

Phase 1, Phase 2

Turning Point Therapeutics
Turning Point Therapeutics

Roma, Italy and 148 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems